REG-argenx to Host Myositis R&D Webinar on June 23, 2026
argenx will host an R&D webinar on June 23, 2026, titled 'R&D Spotlight: Advancing FcRn Leadership into Autoimmune Myositis'. The session is the second in a 'mini' series highlighting the company's pipeline and will focus on myositis, an autoimmune rheumatic disease.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.